You have 9 free searches left this month | for more free features.

City

Dallas (1)

Condition

Paroxysmal Nocturnal Hemoglobinuria (2)

C3 Glomerulopathy (1)

Healthy (1)

PNH - Paroxysmal Nocturnal Hemoglobinuria (1)

aHUS - Atypical Hemolytic Uremic Syndrome (1)

Overall Status

Not yet recruiting (5)

Completed (1)

Sign in for free

Phase

phase 2 (4)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

NovelMed Therapeutics (6)

Collaborator

Labcorp Drug Development Inc (1)

Intervention

nm8074 (6)

placebo (1)

soliris (1)

Study Documents

Intervention Type

drug (6)

Funder Type

Industry (6)

Study Type

Interventional (6)

nm8074

Showing 1 - 6 of 6

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

PNH - Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

Not yet recruiting

PNH - Paroxysmal Nocturnal Hemoglobinuria

NM8074

(no location specified)

Feb 13, 2023

C3 Glomerulopathy Trial (NM8074)

Not yet recruiting

C3 Glomerulopathy

NM8074

(no location specified)

Jan 12, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074, Soliris)

Not yet recruiting

Paroxysmal Nocturnal Hemoglobinuria

NM8074
Soliris

(no location specified)

Jan 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

Not yet recruiting

Paroxysmal Nocturnal Hemoglobinuria

NM8074

(no location specified)

Jan 17, 2023

aHUS - Atypical Hemolytic Uremic Syndrome Trial (NM8074)

Not yet recruiting

aHUS - Atypical Hemolytic Uremic Syndrome

NM8074

(no location specified)

Jan 23, 2023

Healthy Trial in Dallas (NM8074, Placebo)

Completed

Healthy

NM8074
Placebo

Dallas, Texas

Covance Clinical Unit

Nov 29, 2022